Emanuela Leone
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Hematology top 2%
- Multiple Myeloma Research and Treatments
Papers in
-
- RNA Interference and Gene Delivery 7
- Epigenetics and DNA Methylation 3
- Advanced biosensing and bioanalysis techniques 3
- Protein Degradation and Inhibitors 2
- Histone Deacetylase Inhibitors Research 2
-
- MicroRNA in disease regulation 9
- Co-authors
- Pierfrancesco Tassone (16 shared papers)Maria Teresa Di Martino (16 shared papers)Nicola Amodio (14 shared papers)Antonino Neri (11 shared papers)Pierosandro Tagliaferri (7 shared papers)Antonio Giordano (6 shared papers)Annamaria Gullà (10 shared papers)Marco Rossi (8 shared papers)
- Journals
- Blood (4 papers)PLoS ONE (2 papers)Current Cancer Drug Targets (2 papers)Oncotarget (2 papers)Journal of Cellular Physiology (2 papers)
- Partner nations
- ItalyUnited StatesCanada
In The Last Decade
Emanuela Leone
20 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 82
- Cancer Research 591
- Hematology 320
- Molecular Biology 819
- Pathology and Forensic Medicine 171
- Oncology 195
Countries citing papers authored by Emanuela Leone
This map shows the geographic impact of Emanuela Leone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emanuela Leone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emanuela Leone more than expected).
Fields of papers citing papers by Emanuela Leone
This network shows the impact of papers produced by Emanuela Leone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emanuela Leone. The network helps show where Emanuela Leone may publish in the future.
Co-authors
The 25 scholars most cited alongside Emanuela Leone, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 186 | |
| 2 | 2012 | 168 | |
| 3 | 2012 | 127 | |
| 4 | 2013 | 123 | |
| 5 | 2015 | 94 | |
| 6 | 2014 | 85 | |
| 7 | 2001 | 85 | |
| 8 | 2013 | 82 | |
| 9 | 2014 | 76 | |
| 10 | 2012 | 73 | |
| 11 | 2011 | 72 | |
| 12 | 2012 | 40 | |
| 13 | 2015 | 17 | |
| 14 | 2013 | 2 | |
| 15 | 2013 | 1 | |
| 16 | 2014 | 1 | |
| 17 | Identifying the Breakdowns in How Students and Faculty Interpret Course Objectives. | 2019 | 1 |
| 18 | 2012 | 1 | |
| 19 | 2015 | 1 | |
| 20 | [1% tioconazole powder in the treatment of dermatomycoses]. | 1988 | 1 |
About Emanuela Leone
Emanuela Leone is a scholar working on Molecular Biology, Cancer Research, Pathology and Forensic Medicine, Hematology and Oncology, having authored 22 papers that have together received 1.2k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (9 papers), RNA Interference and Gene Delivery (7 papers), Cancer Mechanisms and Therapy (4 papers), Multiple Myeloma Research and Treatments (4 papers), Epigenetics and DNA Methylation (3 papers), Advanced biosensing and bioanalysis techniques (3 papers), Protein Degradation and Inhibitors (2 papers) and Histone Deacetylase Inhibitors Research (2 papers). The work is most often cited by research in Cancer Research (591 citations), Hematology (320 citations), Molecular Biology (819 citations), Pathology and Forensic Medicine (171 citations) and Oncology (195 citations). Emanuela Leone has collaborated with scholars based in Italy, United States and Canada. Frequent co-authors include Pierfrancesco Tassone, Maria Teresa Di Martino, Nicola Amodio, Antonino Neri, Pierosandro Tagliaferri, Antonio Giordano, Annamaria Gullà, Marco Rossi, Umberto Foresta and Michele Caraglia. Their work appears in journals such as Blood, PLoS ONE, Current Cancer Drug Targets, Oncotarget and Journal of Cellular Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.